
- Applied Clinical Trials-11-01-2006
- Volume 0
- Issue 0
eShowcase: iPlan Flow
Software disentangles delivery efficacy from drug efficacy, improving trial results
Software disentangles delivery efficacy from drug efficacy, improving trial results
BrainLab AG (Chicago, IL) has developed a system that allows targeted drug delivery into the brain for treating tumors, a technology that the company says could improve the results of drug trials and ultimately enhance the chances of regulatory approval during trials.
iPlan Flow
iPlan Flow addresses a difficult challenge, since the tight coating of blood vessels protects the brain and prevents fluids from entering it. Delivering enough drug concentration to specific brain cells is therefore problematic due to varying fluid dynamics. The technology uses magnetic resonance imaging to develop a three-dimensional image of the patient's brain. Then, it calculates the drug's distribution patterns, enabling a surgeon to identify the proper locations to place fluid delivery catheters. Potential applications include chemotherapy, gene therapy, molecular-targeted therapy, immunotherapy, and radio-immunotherapy.
BrainLab AG, (800) 784-7700,
Articles in this issue
almost 19 years ago
Building Your Clinical IT Teamalmost 19 years ago
Tough Trials Ahead for Europe's Drug Industryalmost 19 years ago
Experts Urge Major Overhaul at FDAalmost 19 years ago
Recruitment & Consent in Indiaalmost 19 years ago
Pharmacogenomics Enters the Japanese Marketalmost 19 years ago
Meet the EAB: Somesh Nigamalmost 19 years ago
Merging eHR & EDC Conferencealmost 19 years ago
Deploying Mobile Devices in Clinical Trials: Part Twoalmost 19 years ago
eShowcase: Clintrace 4.1almost 19 years ago
eShowcase: PharmaReady V3.0Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.